Company Overview - Beximco Pharmaceuticals is a leading manufacturer and exporter of medicines based in Bangladesh, incorporated in 1976 [2] - The company initially imported products from Bayer, Germany, and Upjohn, USA, before starting its own manufacturing in 1980 under licensing arrangements [2] - Beximco Pharma launched its own formulation brands in 1983 and has been committed to providing access to contemporary medicines globally [2] Stock Performance - Beximco Pharmaceuticals' stock increased by 5.9%, with shares last traded at GBX 45 [1][4] - The stock crossed above its fifty-day moving average of GBX 41.80 during trading, reaching a high of GBX 45 [4] - The company has a market capitalization of £200.75 million and a price-to-earnings ratio of 0.03 [1] Financial Ratios - Beximco Pharmaceuticals has a debt-to-equity ratio of 12.47, indicating a high level of debt compared to equity [1] - The current ratio stands at 2.13, suggesting good short-term financial health, while the quick ratio is at 0.37 [1] - The fifty-day moving average price is GBX 41.80, and the two-hundred-day moving average price is GBX 42.40 [1]